Hepatitis B immunoglobulin PH4 (Shandong Taibang Biological Products)

人乙型肝炎免疫球蛋白(pH4，山东泰邦）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHepatitis B immunoglobulin PH4 (Shandong Taibang Biological Products)
Drug Alias Name人乙肝免疫球蛋白(pH4，山东泰邦）
ClassificationBiologics > Blood componentsBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesShandong Taibang Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Taibang Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A